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To find out the sequence requirement of the H-205 peptide, containing an amphipathic leucine zipper motif corresponding to the amino acid (a.a.)
region 205–234 of hemolysin E (HlyE) to induce efficient permeation in zwitterionic lipid vesicles, the peptide was extended at the N-terminal after
the addition of seven amino acids from the predicted transmembrane region in the head domain of the protein-toxin. The new peptide, H-198
(a.a. 198–234) and a scrambled mutant peptide of the same size were synthesized, fluorescently labeled and characterized functionally and
structurally. The results showed that H-198 induced significantly higher permeation in the zwitterionic PC/Chol lipid vesicles than its shorter
version, H-205. H-198 formed large aggregates in the PC/Chol vesicles unlike H-205 and also adopted more helical structure in the membrane
mimetic environments compared to that of H-205. Fluorescence energy transfer experiments by flow cytometry indicated that only H-198 but
not its mutant or H-205 oligomerized in the zwitterionic lipid vesicles, while in the negatively charged lipid vesicles both H-198 and H-205
formed oligomeric assembly. The results suggest a probable role of the hydrophobic residues of the head domain of HlyE in inducing
permeability in the zwitterionic lipid vesicles by the peptide derived from the a.a. 198–234 of the toxin.
© 2007 Elsevier B.V. All rights reserved.Keywords: Membrane-interaction of hemolysin E; Membrane permeability; Zwitterionic and negatively charged lipid vesicles; Membrane-assembly of hemolysin
E-derived peptides; Peptide–lipid interaction; Fluorescence and flow cytometric studies1. Introduction
Cytolytic proteins and peptides play an important role in
performing offensive and defensive actions in a number of
organisms [1]. Pathogenic bacteria often express virulence factors
that are of fundamental importance for the interactions between the
microorganism and the host [2]. Hemolysin E, also known as silent
hemolysin A (SheA) or cytolysin A (ClyA) by different groups, is a
34-kDa novel pore-forming protein toxin, which is present in
several pathogenic strains of Escherichia coli (including O157),
Salmonella typhi and Shigella flexneri and represents the first
member of a new class of cytotoxin [3]. This protein toxin is also☆ The Central Drug Research Institute Communication number of this article
is 7145.
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doi:10.1016/j.bbamem.2007.03.019considered as a virulence factor in the pathogenic strains of these
bacteria. InE. coliK-12, expression of hlyE gene is activated by the
action of the global transcription factors FNR and CRP (cAMP
receptor protein), in response to oxygen starvation and glucose
starvation, respectively [4,5]. Thus, the expression of this gene
occurs in response to environmental conditions related to infection.
Purified HlyE or E. coli expressing HlyE exhibit cytotoxic and
apoptogenic activities towards human and murine macrophages,
human peripheral monocytes and HeLa cells [5,6].
HlyE has neither N-terminal signal sequence nor undergoes
posttranslational processing like other hemolysins. Recently
Wai et al. have shown that outer membrane vesicles (OMVs)
released from the bacteria contain HlyE protein [7].
Osmotic protection assays and lipid bilayer experiments show
that HlyE forms moderately cation-selective water permeable
pores of diameter 25–30 Å [8,9]. On the basis of hydrophobicity
calculations HlyE has one predicted transmembrane segment
ranging from residue 177 to 203; in addition, there is a second
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crystal structure of hemolysin E shows the rod shape of the
molecule consisting of a bundle of four long helices [10].
However, neither the mechanism of membrane-interaction
nor the exact membrane-interacting segment(s) of this toxin is
known. Recently an amphipathic leucine zipper like motif
located in the α-F region has been characterized [11] which
interacts with phospholipid vesicles. The results showed that the
peptide (H-205) corresponding to the amino acid region (amino
acid 205–234 region) although bound to both zwitterionic (PC/
Chol) and negatively charged (PC/PG/Chol) lipid vesicles
destabilized the negatively charged lipid vesicle very efficiently
and the zwitterionic vesicles comparatively much weakly. Since
the outer membrane of eukaryotic cells is mostly composed of
zwitterionic lipids, in order to look into the potential of this
motif to interact with eukaryotic membrane our objective was to
find out the sequence requirement of the H-205 segment to
induce efficient permeation in the zwitterionic lipid vesicles.
It was anticipated that probably due to lack of sufficient
hydrophobic amino acids (it contains less than 40% hydrophobic
amino acid residues), H-205 did not perturb the zwitterionic lipid
vesicle as efficiently as the negatively charged one. After
looking into the sequence of hemolysin E, it was observed that a
stretch of conserved and hydrophobic residues is present at the
N-terminus of H-205. This stretch of hydrophobic amino acids
also belongs to the C-terminal of the predicted transmembrane
segment in the head region [10]. It was decided to investigate
whether the inclusion of a small hydrophobic segment at the
N-terminus of the H-205 is able to enhance the ability of the
peptide to induce a stronger permeability in the zwitterionic lipid
vesicle or not. Towards this end we have synthesized,
fluorescently labeled and characterized the extended version
(H-198) of the H-205 after the addition of seven hydrophobic
amino acids towards its N-terminal. Also a scrambled mutant
peptide with four amino acids interchanged their positions but
having the same size and composition of H-198 was synthesized
and characterized. The results obtained from these studies have
been discussed in terms of the role of the conserved hydrophobic
residues in the head domain in assisting the H-205 segment
(amino acid 205–234) in inducing higher permeability in the
zwitterionic membrane and the possible contribution of the
H-198 (amino acid 198–234) segment in the target cell
membrane interaction and in the assembly of hemolysin E.
2. Materials and methods
2.1. Materials
Rink amide MBHA resin (loading capacity: 0.4–0.8 mmol/g) and all the N-
α Fmoc and necessary side-chain protected amino acids were purchased from
Novabiochem, Switzerland. Coupling reagents for peptide synthesis like 1-
hydroxybenzotriazole (HOBT), di-isopropylcarbodiimide (DIC), 1,1,3,3-tetra-
methyluronium tetrafluoroborate (TBTU) and N,N′-diisopropylethylamine
(DIPEA) were purchased from Sigma, USA. Dichloromethane, N,N' dimethyl-
formamide (DMF) and piperidine were of standard grades and procured from
reputed local companies. Acetonitrile (HPLC grade) was procured from Merck,
India while trifluoroacetic acid (TFA), trifluoroethanol (TFE) and sodium
dodecyl sulfate (SDS) were purchased from Sigma. Egg phosphatidylcholine
(PC) and egg phosphatidylglycerol (PG) were obtained from Northern LipidsInc., Canada while cholesterol (Chol) was purchased from Sigma. Calcein was
purchased from Sigma and used without further purification. NBD-fluoride (4-
fluoro-7-nitrobenz-2-oxa-1, 3-diazole) and tetramethylrhodamine succinimidyl
ester were procured from Molecular probes (Eugene, OR). The other reagents
used in the present study were of analytical grade and procured from local
companies; buffers were prepared in milli Q water.
2.2. Peptide synthesis, fluorescent labeling and purification
All the peptides were synthesized manually in solid phase. Stepwise
syntheses were carried out on rink amide MBHA resin (0.15 mmol) utilizing the
standard Fmoc chemistry, employing DIC/HOBT or TBTU/HOBT/DIPEA
coupling procedure [12–14]. De-protection of α-amino group and the coupling
of amino acids were checked by Kaiser test [15] for primary amines and
chloranil test for secondary amine [16]. After the synthesis was over, each
peptide was cleaved from the resin with simultaneous de-protection of the side
chains by treatment with a mixture of TFA/phenol/thioanisole/1,2-ethanedithiol/
water (82.5:5:5:2.5:5 v/v) for 6–7 h. Labeling at the N-terminus of a peptide by
fluorescent probes was achieved by a standard procedure as reported earlier
[11,17–19]. In brief, 15–20 mg of resin bound peptide was treated with 25%
piperidine (in DMF) to remove the Fmoc group from the N-terminal amino
group. The resin was washed and dried. Then Fmoc de-protected resin-bound
peptides were incubated either with two–three equivalents of tetramethylrho-
damine succinimidyl ester in dimethylformamide in the presence of 5%
diisopropylethylamine or with NBD-fluoride for 48–72 h, which ultimately
results the formation of Nα-Rho-peptides or Nα-NBD-peptides. After sufficient
labeling, the resins were washed with DMF and DCM in order to remove the un-
reacted fluorescent probes. The peptides were cleaved from the resin as above
and precipitated with dry ether. All the peptides were purified by RP-HPLC on
an analytical Vydac C4 column using a linear gradient of 0–80% acetonitrile in
45 min with a flow rate of 0.6 ml/min. Both acetonitrile and water contained
0.05% TFA. The purified peptides were ∼95% homogeneous as shown by
HPLC. Each peptide was subjected to ES-MS analysis for detection of
molecular mass.
2.2.1. Preparation of small unilamellar vesicles (SUVs)
SUVs were prepared by a standard procedure [11,17–19] as follows. Dry
lipids [either PC/cholesterol (8:1 w/w) or PC/PG/Chol (4:4:1 w/w)] of required
amounts were dissolved in CHCl3/MeOH (2:1 v/v) in small glass vials. Solvents
were evaporated under a stream of nitrogen, which resulted in the formation of a
thin film on the wall of glass vial. The glass vials containing lipid films were
further kept under vacuum for ∼24 h in order to remove even a trace amount of
organic solvents. The thin film was then re-suspended in buffer at a
concentration of 8.2 mg/ml by vortex mixing. The lipid dispersions were then
sonicated in a bath-type sonicator (Laboratory Supplies Company, New York)
for 10–20 min until it became transparent. The lipid concentration was
determined by phosphorus estimation [20].
2.2.2. Circular dichroism (CD) experiments
CD spectra of the peptides were recorded in phosphate buffered saline (PBS,
pH 7.4), 40% TFE and 1% SDS by utilizing a Jasco J-710 spectropolarimeter.
The spectropolarimeter was calibrated routinely with 10-camphor sulphonic
acid. The samples were scanned at room temperature (∼30 °C) with the help of a
capped quartz cuvette of 0.2 cm path length in the wavelength range of 250–
195 nm. An average of 4–6 scans were taken for each sample with a scan speed
of 20 nm/min and data interval of 0.5 nm for peptide concentration of ∼20 μM.
The fractional helicities were calculated by the following formulae [21,22].
Fh ¼ ð½h222  ½h0222Þ=ð½h100222  ½h0222Þ
where [θ]222 was the experimentally observed mean residue ellipticity at
222 nm. The values for [θ]222
100 and [θ]222
0 that correspond to 100 and 0% helix
contents were considered to have mean residue ellipticity values of −32,000 and
−2,000 respectively at 222 nm [22].
2.2.3. Membrane-binding experiments
The affinity of the peptides for phospholipid vesicles was determined by
binding experiments as reported earlier [11,18,23–25]. Briefly, small
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peptide at room temperature. Fluorescence intensities of NBD-labeled peptides
alone and after each addition of lipid vesicles were recorded on a Perkin Elmer
spectrofluorimeter LS-50B, with the excitation wavelength set at 467 nm and
emission at 528 nm. The excitation and emission slits were fixed at 8 nm and
6 nm respectively. The contributions of lipid to any of the recorded signal were
measured by titrating the unlabeled peptide (concentration same as NBD-labeled
peptide) with the same amount of lipid vesicles and were subtracted from the
original signal. The binding isotherms were analyzed by the following equation.
X Tb ¼ KTpCf
where Xb
* is defined as the molar ratio of bound peptide per 60% of the total
lipid, assuming that the peptides were initially partitioned only over the outer
leaflet of the SUVas suggested by Beschiascvilli and Seelig [24]. Kp
* represents
the partition coefficient and Cf indicates the concentration of the free peptide at
equilibrium. Xb was calculated by extrapolating the fluorescence signal, F∞
(fluorescence signal when all the peptide is bound to lipid) from a double-
reciprocal plot of F (peptide fluorescence in the presence of lipid) versus CL
(lipid concentration). Fraction of peptide bound (fb) was determined by the
following equation.
fb ¼ ðF  F0Þ=ðFl  F0Þ
where F is the fluorescence of the peptide when it is bound to lipid and F0 is the
fluorescence of the peptide in its unbound state. If fb is known, Cf can easily be
calculated for each concentration of the lipid. Kp
* can easily be determined from
the slope of the plot of Xb
* and Cf.
2.2.4. Calcein release from the calcein-entrapped lipid vesicles
In order to determine the pore-forming activity of H-198 and its mutant,
peptide-induced release of calcein from calcein-entrapped lipid vesicles was
measured. Calcein-entrapped lipid vesicles were prepared with a self-quenching
concentration (60 mM) of the probe in 10 mM HEPES buffer at pH 7.4 as
reported earlier [26–28]. Briefly, thin film of lipid (either PC/PG/Chol or PC/
Chol) was re-suspended in calcein solution, vortexed for 1–2 min and then
sonicated in a bath-type sonicator. The non-encapsulated calcein was removed
from the liposome suspension by gel filtration using a sephadex G-50 column.
Usually lipid vesicles are diluted to approximately 10 fold after passing through
a G-50 column. The eluted calcein-entrapped vesicles were diluted further in the
same buffer to a final lipid concentration of ∼3.0 μM for the experiment.
Peptide-induced release of calcein from the lipid vesicles was monitored by the
increase in fluorescence due to the dilution of the dye molecules from its self-
quenched state. Fluorescence was monitored at room temperature withFig. 1. Schematic representation, sequence alignment and amino acid sequences o
localization of H-198 segment in it. H-198, shown as extended version of amphipath
like both the putative transmembrane domain TM1 (a.a. 88–101) and TM2 (a.a. 177–
marked. (B) Sequence alignment of H-198 (a.a. 198–234) derived from hemolysin
(EcAv), Salmonella typhi (Styphi) and Shigella flexneri (Shflex). Identical amino a
peptides used in this study. The mutated amino acid is underlined.excitation and emission wavelengths fixed at 490 and 520 nm respectively
with excitation slit of 8 nm and emission slit of 6 nm. Calcein release as
measured by the fluorescence recovery is defined by the equation:
Ft ¼ ½ðIt  I0Þ=ðIf  I0Þ  100%
where It = the observed fluorescence after the addition of a peptide at time t
(after 5 min of the addition of the peptide), I0= the initial fluorescence before
addition of the peptide and If = the total fluorescence, which was determined
after the addition of triton X-100 (0.1% final concentration) to the dye-entrapped
vesicle suspension.
2.2.5. Flow cytometric studies to detect the binding and assembly of the
peptides in lipid vesicles
Fluorescence resonance energy transfer (FRET) experiments with a donor-
labeled peptide and an acceptor-labeled peptide in the presence of lipid vesicles
were also performed as reported earlier [29] by using a Becton Dickinson
FACSCalibur flow cytometer and CellQuest Pro software. The excitation and
emission wavelengths were set at 488 and 530 nm respectively. Equimolar
amounts (2.7 μM) of NBD-labeled peptide (donor) and Rho-labeled peptide
(acceptor) were added to the lipid vesicles. Changes in NBD fluorescence due to
FRET were determined by comparing NBD-fluorescence of the donor in the
presence of Rho-labeled peptide to that when Rho-peptide was replaced with the
respective unlabeled peptide. 104 Events were counted for each experiment.
2.3. Results
In order to find out the amino acid sequence requirement of the amphipathic
leucine zipper motif (H-205 peptide, corresponding to the amino acid region
205–234) to induce efficient permeation in the zwitterionic membrane and also
to understand any possible role of this segment in the membrane-interaction of
hemolysin E, one wild type and one mutant peptide derived from the amino acid
region of 198–234 were designed and synthesized. Fig. 1A shows the schematic
location of the extended version of this amphipathic leucine zipper like motif of
hemolysin E under investigation. The panel A of Fig. 1 also schematically shows
both the putative transmembrane segments with two identified and partially
characterized heptad repeats [11] as marked. The sequence alignment of the
corresponding amino acid region of the proteins of hemolysin E toxin family
indicates that a considerable number of amino acids belonging to all four
proteins have identical sequences (Fig. 1B). Fig. 1C depicts the amino acid
sequences of the unlabeled and fluorescent-labeled wild type peptide H-198 and
the mutant peptide, which has the same size and composition as the wild type
peptide but positions of lysine at 206 with leucine at 215 and isoleucine at 208f H-198 and its analog. (A) Schematic representation of hemolysin E and the
ic leucine zipper like motif (amino acid 198–234) and other important segments
203) and two heptad repeats at a.a. 130–157 and 205–234 have been shown as
E of E. coli with homologous regions of hemolysin sequences of avian E. coli
cids have been marked as bold letters. (C) Designations and sequences of the
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H-205) of the mutant Mu-H-198 was reported earlier (11). In order to understand
the importance of amino acid sequence in the assembly and functional activity of
the peptide H-198, Mu1-H-205 was also extended by adding the seven
hydrophobic amino acids at the N-terminal like the wild type peptide.
2.3.1. H-198 induced stronger permeability in the zwitterionic phospholipid
vesicles than its shorter version H-205
In order to check the ability of H-198 and its analogue to destabilize the lipid
bilayer, release of calcein from calcein-entrapped lipid vesicles in the presence
of these peptides was measured. As shown in the panel A of Figs. 2 and 3, the
extended leucine zipper like peptide (H-198) triggered the release of liposome-
encapsulated calcein in a dose-dependent manner from both the zwitterionic PC/
Chol and negatively charged PC/PG/Chol lipid vesicles respectively. However,
the mutant was less efficient than the wild type H-198 in releasing calcein from
either of the PC/Chol (Fig. 2B) or PC/PG/Chol (Fig. 3B) lipid vesicles indicating
the requirement of specific sequence in destabilizing the lipid vesicles as was
also observed in case of the smaller version of the wild type peptide H-205 [11].
The profiles (Fig. 2C) of H-205-induced weak permeability of PC/Chol lipid
vesicles [11] clearly indicated that H-205 was much less active than its extended
version, H-198 (Fig. 2A) in destabilizing the zwitterionic lipid vesicles. The
plots of fluorescence recovery, which is a measure of peptide-induced
permeability of lipid vesicles, clearly indicated that H-198 was significantly
more active than the mutant in inducing permeability in zwitterionic PC/Chol
(Fig. 2D) and negatively charged PC/PG/Chol (Fig. 3C) lipid vesicles. It is to be
mentioned that the shorter version, H-205, induced a calcein fluorescence
recovery of only 20% at a peptide/lipid molar ratio of 0.7 and fluorescence
recovery of only 8% at a peptide/lipid ratio of 0.2 [11]. However, the present
data indicated that the extended version, H-198 induced a fluorescence recoveryFig. 2. Calcein release induced by H-198, H-205 and the Mu-H-198 from the zwitteri
profiles of calcein release induced by increasing concentrations of H-198, Mu-H-198
to time. In panel A, a, b, c, d and e are 0.15, 0.30, 0.375, 0.450 0.60 μMof H-198; in p
c, are the profiles of H-205 induced calcein release from calcein entrapped PC/Ch
respectively. Panel D depicts the relative pore-forming activity of the peptides in z
recovery with respect to peptide to lipid molar ratio. The concentration of PC/Chol lip
198.∼100% at peptide/lipid ratio of ∼0.20 in PC/Chol lipid vesicles. On the other
hand, H-205 [11] and H-198 showed comparable permeability in the negatively
charged PC/PG/Chol lipid vesicles. For example, both H-205 and H-198
induced 100% fluorescence recovery in PC/PG/Chol vesicles at a peptide/lipid
molar ratio range of 0.14–0.15. Thus the results suggested that the addition of
seven hydrophobic amino acids at the N-terminal of H-205 did not show much
effect on its permeability towards the negatively charged lipid vesicles.
Also, it was observed that NBD- or Rho-labeled H-198 induced very similar
calcein release from the calcein-entrapped lipid vesicles as that of the unlabeled
H-198, which indicated that labeling of H-198 did not disturb its pore-forming
activity significantly (data not shown). Thus the results clearly suggest that H-
198 induced appreciably stronger permeation in the zwitterionic PC/Chol
vesicles than its shorter version H-205. Or in other words the addition of seven
hydrophobic amino acids at the N-terminal of H-205 enhanced the ability of the
peptide to destabilize the zwitterionic membrane.
2.3.2. Both H-198 and its mutant peptides bound to phospholipid membrane
In order to understand the basis of enhanced permeability of zwitterionic
lipid vesicles in the presence of H-198 compared to that of the shorter version H-
205, the interaction of the peptides to lipid vesicles was studied in detail. The
binding of H-198 and its mutant to phospholipid vesicles was examined by
employing their NBD-labeled analogs. The sensitivity of the NBD probe to the
dielectric constant of the medium has been exploited extensively to detect the
binding of the NBD-labeled peptide to membrane [11,23,30–32]. Fluorescence
emission spectra of NBD-labeled H-198 were recorded in aqueous buffer and in
the presence of phospholipid vesicles. The fluorescence spectra of the wild type
and mutant peptides exhibited broad emission maxima at around 540 nm in
phosphate buffer indicating the location of the NBD-probe, attached to the N-
terminal of the peptides in the hydrophilic environment [32]. However, in theonic PC/Chol lipid vesicles entrapped with calcein. Panels A, B, and C show the
and H-205 respectively as measured by the increase in fluorescence with respect
anel B, a, b and c are 0.15, 0.30 and 0.6 μMof Mu-H-198 and in panel C, a, b and
ol lipid vesicles (3.0 μM) with peptide concentration 0.69, 1.38, and 2.07 μM
witterionic lipid vesicles as shown by the plots of percentage of fluorescence
id vesicles was 2.5 μM. Symbols: closed squares, H-198, closed circles, Mu-H-
Fig. 4. Binding of NBD-labeled H-198 and its mutant Mu-H-198 to negatively
charged PC/PG/Chol and zwitterionic PC/Chol lipid vesicles. Squares and
triangle represent NBD-labeled H-198 and NBD-labeled Mu-H-198 respec-
tively. Closed symbols, 0.2 μM of NBD-labeled peptides in PBS; open symbols,
NBD-labeled peptides in the presence of 412 μM of PC/PG/Chol and plus
centered symbols, NBD-labeled peptides in the presence of 412 μM of PC/Chol
lipid vesicles.
Fig. 3. Calcein release induced by H-198 and the mutant Mu-H-198 from the
negatively charged PC/PG/Chol lipid vesicles entrapped with calcein. Panels A and
B show the profiles of calcein release induced by increasing concentrations of H-198
andMu-H-198. In panel A, a, b, c, d and e are .03, 0.06, 0.08, 0.16 and 0.4 μMofH-
198. In panel B, a, b, c and d are 0.16, 0.32, 0.64 and 0.8 μMofMu-H-198. Panel C
represents the plots of percentage of fluorescence recovery induced by the peptides
with respect to peptide to lipid molar ratio in PC/PG/Chol (2.5 μM) lipid vesicles.
Symbols: closed squares, H-198 and closed circles, Mu-H-198.
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of the NBD-labeled wild type and mutant peptide exhibited a blue shift of
emission maxima concomitant with significant increase in fluorescence (Fig. 4).
These shifts of emission maxima towards the shorter wavelength with
enhancement of fluorescence indicated the relocation of the probe in the
hydrophobic environment due to binding of the peptides to phospholipid
vesicles. Wild type H-198 exhibited an emission maximum at ∼527 nm in the
presence of zwitterionic PC/Chol lipid vesicles, which was much shorter than
the emission maximum of 533 nm, characteristic of the location of the NBD
probe on the surface of membrane [33]. This emission maximum further
suggested that the N-terminal of H-198 was to some extent inserted in the bilayer
of the zwitterionic lipid vesicles. Furthermore, H-198 exhibited an emission
maximum at ∼526 nm in the negatively charged phospholipid vesicles (PC/PG/
Chol) also indicating the location of its N-terminal towards the interior of the
membrane. The NBD-labeled mutant peptide displayed an emission maximum
at 531–532 nm in the presence of either PC/Chol or PC/PG/Chol lipid vesicles
suggesting that its N-terminal was most probably located on the surface of the
membrane. It is to be pointed out that the NBD-labeled H-205 exhibited
emission maxima in the wavelength ranges of 529–530 and 526–527 nm in PC/Chol and PC/PG/Chol lipid vesicles respectively [11]. Thus a comparison of
emission maxima of H-198 and H-205 in both kinds of lipid vesicles indicated
that the addition of seven hydrophobic amino acids at the N-terminal of H-205
probably assisted in its insertion in the zwitterionic lipid vesicles although
without showing much effect on its localization in the negatively charged lipid
vesicles. These results clearly demonstrated that the synthetic wild type and the
mutant peptide derived from the amino acid region 198–234 of HlyE bound to
both zwitterionic and negatively charged lipid vesicles but their localization was
influenced by their amino acid sequence and also lipid composition of the
membrane.
2.3.3. H-198 exhibited slightly higher affinity than the mutant toward
phospholipid vesicles
The affinity of H-198 and its mutant to the phospholipid vesicles was
determined by the binding experiments utilizing their NBD-labeled analogues
and SUVs with different lipid composition. Fluorescence signals of the NBD-
labeled peptides as a result of their binding to the phospholipid membrane were
plotted with respect to lipid/peptide molar ratio. Fig. 5A depicts the binding
curve for H-198 in PC/Chol vesicles, while Fig. 5B and C describe such plots for
H-198 andMu-H-198 in PC/PG/Chol lipid vesicles. All the plots show a gradual
increase in fluorescence with increase in lipid concentration indicating a
progressive binding of the NBD-labeled peptides to the lipid vesicles. Binding
isotherms were generated by plotting Xb
* with respect to Cf as has been described
in Materials and methods. Partition coefficients of the NBD-labeled peptides to
the phospholipid vesicles were estimated from the slope of the binding isotherms
after extrapolating to zero. NBD-labeled H-198 exhibited an appreciable affinity
for PC/Chol lipid vesicles as indicated (panel D) by its partition coefficient of
2.0 (±0.1)×104 M−1, which is similar to that of the surface-active peptides,
derived from anti-microbial peptides, bacterial toxins and viral fusion proteins
[18,25,34]. The estimated partition coefficient for H-198 in PC/PG/Chol lipid
vesicles was 2.3 (±0.1)×104 M−1, and the mutant peptide exhibited a partition
coefficient of 1.66 (±0.1)×104 M−1 in the same kind of lipid vesicles. It is to be
mentioned that H-205 exhibited a partition coefficient of 1.5 (±0.1)×104 M−1 in
PC/Chol vesicles [11], which suggested that the extended version, H-198
possess a slightly higher affinity for zwitterionic lipid vesicles than its shorter
version H-205. The nature of the binding curve also provides an idea about the
assembly of a peptide in membrane. The linear nature of binding isotherm of
NBD-labeled mutant peptide in PC/PG/Chol vesicles (Fig. 5F) suggests that the
binding of the peptide to lipid vesicles was a simple adhesion process and NBD-
Mu-H-198 peptide molecules did not form large aggregates in the negatively
charged lipid vesicles. However, the binding isotherm of NBD-labeled H-198 in
PC/Chol (Fig. 5D) and PC/PG/Chol lipid vesicles (Fig. 5E) bent downward
appreciably and deviated from linearity. As suggested earlier, this kind of curve
Fig. 5. Determination of affinity of the NBD-labeled (0.2 μM) wild type and mutant peptides to phospholipid vesicles as determined by titration with PC/Chol and PC/
PG/Chol lipid vesicles. Panels A, B and C are binding curves of NBD labeled H-198 in PC/Chol, NBD labeled H-198 in PC/PG/Chol and Mu-H-198 in PC/PG/Chol
lipid vesicles; Panel D, binding isotherm of NBD-H-198 in PC/Chol vesicles; panels e and F are binding isotherms of NBD-H-198 andMu-H-198 in PC/PG/Chol lipid
vesicles.
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Furthermore, these binding isotherms revealed that NBD-labeled H-198 formed
large aggregates in both zwitterionic and negatively charged lipid vesicles. It is
to be pointed out that the nature of binding of H-198 to zwitterionic lipid vesicles
was contrasting to H-205 in the sense that while the former peptide formed
larger aggregates there in, the latter only formed smaller aggregates [11].
2.3.4. H-198 adopted significant helical structures in the membrane mimetic
environments
Circular dichroism studies were carried out in order to determine the
secondary structures of these peptides. Secondary structures of H-198 and its
mutant were determined in aqueous buffer (PBS), and in membrane mimetic
environments like SDS micelles and 40% TFE in water with the help of mean
residual ellipticity values at 222 nm. Both the peptides exhibited mostly random
coil structure in PBS and therefore not presented. However, the extent of their
helical structures increased significantly in 40% TFE and 1% SDS (Fig. 6). The
mean residual ellipticity values at 222 nm of the CD spectra of wild type H-198
in 40% TFE and 1% SDS were −31,554 and −25,868 which correspond to
98.5% and 79.5% helical structures respectively. For Mu-H-198 mean residueellipticity values at 222 nm in 40% TFE and 1% SDS were −24,866 and
−21,986 which correspond to helix contents of 76.2% and 66.6% respectively.
As reported earlier the helix contents of H-205 in 40% TFE and 1% SDS were
77.8 and 68.7% respectively [11]. Thus the results indicated that the addition of
seven amino acids at the N-terminal of H-205 resulted an appreciable increase in
its helix contents. Altogether, these results indicated that the wild type H-198
adopted significant helical structure in both 40% TFE and 1% SDS and
mutations resulted in a slight decrease in helical structure.
2.3.5. H-198 exhibited higher affinity than its analogs to phospholipid vesicles
and assembled therein as evidenced by flow cytometric studies
In order to evaluate any possible role of this extended leucine zipper like
motif in the assembly of hemolysin E in membrane, fluorescence energy transfer
experiments were performed with the help of a flow cytometer as described in
Materials and methods. Zwitterionic PC/Chol lipid vesicles treated with NBD-
H-198 peptide showed higher fluorescence (the X-axis vales) compared to that
treated with NBD-H-205. Furthermore, the lipid vesicles treated with Mu-H-198
exhibited even slightly lower fluorescence. Probably, the results indicate that H-
198 possesses higher affinity than H-205 toward the zwitterionic lipid vesicles
Fig. 6. Determination of secondary structures of wild type H-198 and Mu-H-198
in SDS micelles and 40% TFE/water by recording their CD spectra in the
corresponding environment. Symbols: solid line, H-198 in 40% TFE; dash, H-
198 in 1% SDS; dot, Mu-H-198 in 40% TFE, dash dot, Mu H-198 in 1% SDS.
The concentration of H-198 and its mutant was 21.0 μM.
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support the binding studies of the NBD-labeled peptides to phospholipid
vesicles. However, when the corresponding Rho-labeled peptide was added to
membrane-bound NBD-H-198 significant decrease in NBD-fluorescence was
observed (Fig. 7B) indicating an energy transfer event, which could be due to
oligomeric assembly of the peptide in zwitterionic lipid vesicles as was reported
for perfringolysin O in the human red blood cells [29]. The extent of energy
transfer was less for the peptide H-205 and almost no energy transfer was
observed for Mu-H-198. The data probably indicated either negligible ability
(H-205) or inability (Mu-H-198) of the peptide molecules to form oligomeric
assembly in the zwitterionic lipid vesicles. However, the picture was a bit
different in the negatively charged lipid vesicles. Not much difference was
observed between the fluorescence levels of the PC/PG/Chol lipid vesicles
treated with NBD-labeled H-198 or H-205. Also, a significant energy transfer
was observed when Rho-H-205 or Rho-H-198 was added to PC/PG/Chol lipid
vesicles, bound to the corresponding NBD-labeled peptides indicating that both
the peptides formed oligomers in the negatively charged lipid vesicles.
However, no appreciable energy transfer was observed between NBD-Mu-H-
198 and Rho-Mu-H-198 in PC/PG/Chol vesicles as was observed in the PC/
Chol lipid vesicles. Altogether, the flow cytometric studies indicated that in the
negatively charged PC/PG/Chol vesicles both H-205 and H-198 and in the
zwitterionic PC/Chol vesicles only H-198 formed oligomeric assembly.Fig. 7. Detection of oligomeric assembly of H-205, H-198 and Mu-H-198 onto
both PC/Chol and PC/PG/Chol lipid vesicles (825 μM) by employing energy
transfer experiments with the help of a flow cytometer. Equimolar amounts
(2.7 μM) of donor (NBD) labeled H-205, H-198 or Mu-H-198 (D) and either the
corresponding unlabeled peptide (U) or acceptor (Rho) labeled peptide (A)
incubated with PC/Chol (panels A, B and C) or PC/PG/Chol (panels D, E and F)
lipid vesicles at room temp. for ∼5 min and then analyzed by flow cytometry.
Grey lines represent (D+U), while black lines represent (D+A) with lipid
vesicles. For each experiment 10,000 events were counted.3. Discussion
The results depicted here clearly indicated that the synthetic
H-198 segment of E. coli toxin hemolysin E induced
zwitterionic PC/Chol lipid vesicle permeation much more
efficiently than its shorter version, H-205 [11], a peptide
corresponding to an amphipathic leucine zipper motif located in
the a.a. region 205–234 and the mutant peptide, which has the
same composition as H-198 but with four amino acids
interchanged their positions. Another alanine-substituted
mutant (Mu2-H-198) of H-205 (heptadic leucine at position
215 replaced by alanine), which was reported earlier [11], was
also extended to the same size as the H-198. However, since this
alanine-substituted mutant exhibited very similar and signifi-
cantly reduced membrane permeability (Supplementary Fig. 1)
like the scrambled mutant (Mu-H-198), detailed structural
studies of this mutant were not performed. The results describedhere further suggested that the addition of the hydrophobic
amino acid residues from the predicted transmembrane domain
in the head region of HlyE to the H-205 enhances the peptide-
induced permeability of zwitterionic lipid vesicles and also
assists in self-assembly of the peptide in the same kind of
phospholipid vesicles.
The binding and assembly of a peptide in a particular kind of
lipid vesicles are the key issues related to its efficiency to induce
permeation therein. Binding experiments employing the NBD-
labeled peptides indicated that H-198 possesses slightly higher
affinity than H-205 towards the zwitterionic lipid vesicles (Fig.
5). Flow cytometric studies, which showed that the zwitterionic
1581S.P. Yadav et al. / Biochimica et Biophysica Acta 1768 (2007) 1574–1582lipid vesicles treated with NBD-H-198 exhibited maximum
fluorescence followed by the lipid vesicles treated with NBD-
H-205 and NBD-Mu-H-198 also support the binding experi-
ments (Fig. 7). The higher fluorescence of zwitterionic vesicles
in the presence of NBD-H-198 could be due to the binding of
more fluorescent peptide molecules to the lipid vesicles and/or
as a result of interaction of the peptide molecules with more
hydrophobic part of the phospholipid membrane. That H-198
could interact with more hydrophobic environment of the
zwitterionic lipid vesicles than H-205 is consistent with the
lower emission maximum (∼527 nm, Fig. 4)) of NBD-H-198 in
the same kind of lipid vesicles than that of its shorter version
(529–530 nm) [11].
Energy transfer experiments by flow cytometric approach
suggested that the extended version, H-198 formed oligomeric
assembly in both zwitterionic and negatively charged lipid
vesicles whereas H-205 formed oligomers only in the
negatively charged lipid vesicles (Fig. 7). Similar oligomeric
assembly of cholesterol dependent toxins in human red blood
cells was detected by flow cytometric studies as was reported
earlier [29]. The result was also consistent with the shape of the
binding isotherm (Fig. 5), which showed clear deviation from
linearity for H-198 in both zwitterionic and negatively charged
lipid vesicles. It has already been reported that H-205 formed
large aggregates only in the negatively charged lipid vesicles
but not in zwitterionic vesicles [11]. Thus the result indicated
the role of seven hydrophobic amino acids from the head region
that were added to the N-terminal of H-205 in altering its
assembly in zwitterionic lipid vesicles. Circular dichroism
studies (Fig. 6) indicated that H-198 peptide adopted almost a
complete helical structure in membrane mimetic environment
suggesting that this segment may contribute in the secondary
structure of the whole protein.
Altogether the results suggested that the ability of H-198 to
induce higher permeability in the zwitterionic lipid vesicles
could be due to the stronger binding and oligomeric assembly
of the peptide in the lipid vesicles compared to that of H-205
and H-198 mutant. Moreover, H-198 adopted higher helical
structure in membrane mimetic environment than H-205. Thus
the results also indicated the role of seven amino acids (a.a.
198–204) from the predicted transmembrane segment of the
head region of hemolysin E in increasing the membrane-
destabilization potency of H-205 region in zwitterionic lipid
vesicles. Interestingly, the similar oligomeric assembly of H-
198 and H-205 in negatively charged lipid vesicles is
consistent with their similar permeability in the same kind of
membrane. Both H-205 [11] and its extended version induced
comparable fluorescence recovery at similar peptide/lipid
molar ratio in the negatively charged lipid vesicles. The results
probably indicated that the amino acid region 205–234
corresponding to the peptide H-205 already possess the
amino acid sequence to induce permeation in the negatively
charged lipid vesicles and assembly there in and therefore, the
addition of seven amino acids from the predicted transmem-
brane domain to the N-terminal of H-205 peptide did not show
a significant effect on the activity of the peptides in the same
kind of vesicles.The actual membrane-interacting segment of hemolysin E is
still not known. However, the site directed mutagenesis [8] and
model building studies [10,35] suggested that the predicted
transmembrane segment in the head domain, which also
contains the β-tongue region, could play an important role in
the membrane-interaction and toxic activity of the protein toxin.
Since the eukaryotic membrane is composed of zwitterionic
lipids the studies described here indicated a possible contribu-
tion of the segment consisting of a leucine zipper like motif and
a small part of the transmembrane segment of the head region in
the interaction and assembly of the protein to the target cell
membrane. Importantly, the date also suggests that a peptide
probably needs at least a certain number of hydrophobic amino
acids in order to efficiently destabilize the zwitterionic lipid
vesicles. In conclusion the results depicted here suggest that the
addition of a small hydrophobic stretch from the predicted
transmembrane segment of head region to the H-205 assists in
the self-assembly of the peptide in zwitterionic lipid vesicles
and enhances the peptide-induced permeability of the same kind
of lipid vesicles. Probably, H-198 segment with a.a. 198–234 of
HlyE may contribute in the binding and assembly of the protein
toxin in target cell membrane.
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